Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Current Assets (2016 - 2026)

Biomerica's Current Assets history spans 16 years, with the latest figure at $4.1 million for Q1 2026.

  • Quarterly results put Current Assets at $4.1 million for Q1 2026, down 33.54% from a year ago — trailing twelve months through Feb 2026 was $4.1 million (down 33.54% YoY), and the annual figure for FY2025 was $4.9 million, down 36.94%.
  • Current Assets for Q1 2026 was $4.1 million at Biomerica, down from $5.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $15.2 million in Q1 2022 to a low of $4.1 million in Q1 2026.
  • The 5-year median for Current Assets is $7.7 million (2024), against an average of $8.1 million.
  • The sharpest move saw Current Assets surged 41.23% in 2022, then plummeted 57.44% in 2023.
  • Year by year, Current Assets stood at $8.1 million in 2022, then grew by 26.75% to $10.3 million in 2023, then plummeted by 42.08% to $5.9 million in 2024, then fell by 12.68% to $5.2 million in 2025, then dropped by 20.57% to $4.1 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $4.1 million, $5.2 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.